annual CFO:
-$40.52M-$9.10M(-28.98%)Summary
- As of today (June 2, 2025), TGTX annual cash flow from operations is -$40.52 million, with the most recent change of -$9.10 million (-28.98%) on December 31, 2024.
- During the last 3 years, TGTX annual CFO has risen by +$255.12 million (+86.29%).
- TGTX annual CFO is now -46686.37% below its all-time high of -$86.60 thousand, reached on December 31, 2011.
Performance
TGTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$28.71M-$3.07M(-11.99%)Summary
- As of today (June 2, 2025), TGTX quarterly cash flow from operations is -$28.71 million, with the most recent change of -$3.07 million (-11.99%) on March 1, 2025.
- Over the past year, TGTX quarterly CFO has dropped by -$20.51 million (-249.88%).
- TGTX quarterly CFO is now -134.31% below its all-time high of $83.70 million, reached on September 30, 2023.
Performance
TGTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$61.02M-$20.51M(-50.62%)Summary
- As of today (June 2, 2025), TGTX TTM cash flow from operations is -$61.02 million, with the most recent change of -$20.51 million (-50.62%) on March 1, 2025.
- Over the past year, TGTX TTM CFO has dropped by -$81.31 million (-400.88%).
- TGTX TTM CFO is now -189.98% below its all-time high of $67.82 million, reached on June 30, 2024.
Performance
TGTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TGTX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.0% | -249.9% | -400.9% |
| 3 y3 years | +86.3% | +58.2% | +78.4% |
| 5 y5 years | +69.5% | +53.8% | +62.2% |
TGTX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.0% | +86.3% | -134.3% | +58.2% | -190.0% | +78.4% |
| 5 y | 5-year | -29.0% | +86.3% | -134.3% | +67.0% | -190.0% | +79.4% |
| alltime | all time | <-9999.0% | +86.3% | -134.3% | +67.0% | -190.0% | +79.4% |
TGTX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$28.71M(+12.0%) | -$61.02M(+50.6%) |
| Dec 2024 | -$40.52M(+29.0%) | -$25.64M(+110.1%) | -$40.52M(+44.3%) |
| Sep 2024 | - | -$12.21M(-320.5%) | -$28.09M(-141.4%) |
| Jun 2024 | - | $5.54M(-167.5%) | $67.82M(+234.4%) |
| Mar 2024 | - | -$8.21M(-37.9%) | $20.28M(-164.6%) |
| Dec 2023 | -$31.41M(-82.2%) | -$13.21M(-115.8%) | -$31.41M(-25.3%) |
| Sep 2023 | - | $83.70M(-299.3%) | -$42.07M(-73.7%) |
| Jun 2023 | - | -$42.01M(-29.9%) | -$160.27M(-4.2%) |
| Mar 2023 | - | -$59.90M(+151.0%) | -$167.38M(-5.0%) |
| Dec 2022 | -$176.17M(-40.4%) | -$23.87M(-30.8%) | -$176.17M(-26.4%) |
| Sep 2022 | - | -$34.49M(-29.8%) | -$239.21M(-12.0%) |
| Jun 2022 | - | -$49.12M(-28.5%) | -$271.92M(-3.9%) |
| Mar 2022 | - | -$68.69M(-21.0%) | -$282.97M(-4.3%) |
| Dec 2021 | -$295.63M(+37.8%) | -$86.91M(+29.3%) | -$295.63M(+13.4%) |
| Sep 2021 | - | -$67.20M(+11.7%) | -$260.75M(+4.3%) |
| Jun 2021 | - | -$60.17M(-26.0%) | -$250.08M(+7.0%) |
| Mar 2021 | - | -$81.36M(+56.4%) | -$233.75M(+9.0%) |
| Dec 2020 | -$214.51M(+61.5%) | -$52.03M(-8.0%) | -$214.51M(+11.2%) |
| Sep 2020 | - | -$56.53M(+29.0%) | -$192.87M(+13.8%) |
| Jun 2020 | - | -$43.83M(-29.4%) | -$169.54M(+4.9%) |
| Mar 2020 | - | -$62.12M(+104.4%) | -$161.57M(+21.7%) |
| Dec 2019 | -$132.81M(+3.0%) | -$30.39M(-8.5%) | -$132.81M(-2.4%) |
| Sep 2019 | - | -$33.20M(-7.4%) | -$136.10M(+0.1%) |
| Jun 2019 | - | -$35.86M(+7.5%) | -$135.91M(+1.2%) |
| Mar 2019 | - | -$33.35M(-1.0%) | -$134.23M(+4.1%) |
| Dec 2018 | -$128.93M(+37.5%) | -$33.69M(+2.1%) | -$128.93M(+10.1%) |
| Sep 2018 | - | -$33.01M(-3.4%) | -$117.09M(+9.6%) |
| Jun 2018 | - | -$34.18M(+21.9%) | -$106.86M(+7.4%) |
| Mar 2018 | - | -$28.04M(+28.3%) | -$99.50M(+6.1%) |
| Dec 2017 | -$93.76M(+52.2%) | -$21.86M(-4.0%) | -$93.76M(+5.4%) |
| Sep 2017 | - | -$22.77M(-15.1%) | -$88.93M(+9.5%) |
| Jun 2017 | - | -$26.83M(+20.3%) | -$81.19M(+20.8%) |
| Mar 2017 | - | -$22.30M(+31.0%) | -$67.21M(+9.1%) |
| Dec 2016 | -$61.59M(+37.8%) | -$17.02M(+13.2%) | -$61.59M(+7.2%) |
| Sep 2016 | - | -$15.04M(+17.1%) | -$57.47M(+8.3%) |
| Jun 2016 | - | -$12.85M(-22.9%) | -$53.08M(+1.1%) |
| Mar 2016 | - | -$16.67M(+29.2%) | -$52.48M(+17.4%) |
| Dec 2015 | -$44.69M(+27.5%) | -$12.90M(+21.0%) | -$44.69M(-4.7%) |
| Sep 2015 | - | -$10.66M(-13.0%) | -$46.90M(+5.9%) |
| Jun 2015 | - | -$12.25M(+37.9%) | -$44.29M(+24.4%) |
| Mar 2015 | - | -$8.88M(-41.2%) | -$35.61M(+1.6%) |
| Dec 2014 | -$35.06M(+226.5%) | -$15.11M(+87.6%) | -$35.06M(+41.5%) |
| Sep 2014 | - | -$8.05M(+125.3%) | -$24.78M(+38.6%) |
| Jun 2014 | - | -$3.57M(-57.1%) | -$17.88M(+6.0%) |
| Mar 2014 | - | -$8.33M(+72.7%) | -$16.86M(+57.0%) |
| Dec 2013 | -$10.74M(+107.0%) | -$4.82M(+318.0%) | -$10.74M(+59.1%) |
| Sep 2013 | - | -$1.15M(-54.9%) | -$6.75M(-21.4%) |
| Jun 2013 | - | -$2.56M(+16.0%) | -$8.59M(+31.5%) |
| Mar 2013 | - | -$2.20M(+164.6%) | -$6.53M(+25.9%) |
| Dec 2012 | -$5.19M(+5890.8%) | -$833.30K(-72.2%) | -$5.19M(+17.6%) |
| Sep 2012 | - | -$2.99M(+498.9%) | -$4.41M(+204.6%) |
| Jun 2012 | - | -$499.80K(-42.0%) | -$1.45M(<-9900.0%) |
| Mar 2012 | - | -$861.60K(+1425.0%) | $0.00(-100.0%) |
| Dec 2011 | -$86.60K(-95.6%) | -$56.50K(+87.7%) | -$86.60K(-84.9%) |
| Sep 2011 | - | -$30.10K(-103.2%) | -$571.80K(-40.1%) |
| Jun 2011 | - | $948.20K(-200.0%) | -$954.40K(-58.7%) |
| Mar 2011 | - | -$948.20K(+75.0%) | -$2.31M(+17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$1.97M(+87.7%) | -$541.70K(+31.3%) | -$1.97M(+12.2%) |
| Sep 2010 | - | -$412.70K(+0.5%) | -$1.76M(+18.3%) |
| Jun 2010 | - | -$410.80K(-32.1%) | -$1.48M(+47.1%) |
| Mar 2010 | - | -$604.80K(+84.9%) | -$1.01M(-3.9%) |
| Dec 2009 | -$1.05M(-76.4%) | -$327.10K(+132.2%) | -$1.05M(-36.1%) |
| Sep 2009 | - | -$140.90K(-319.8%) | -$1.64M(-22.6%) |
| Jun 2009 | - | $64.10K(-109.9%) | -$2.12M(-41.5%) |
| Mar 2009 | - | -$645.80K(-29.8%) | -$3.63M(-18.4%) |
| Dec 2008 | -$4.44M(-56.6%) | -$919.80K(+48.3%) | -$4.44M(-9.4%) |
| Sep 2008 | - | -$620.30K(-57.0%) | -$4.91M(-30.3%) |
| Jun 2008 | - | -$1.44M(-1.3%) | -$7.04M(-25.9%) |
| Mar 2008 | - | -$1.46M(+5.7%) | -$9.51M(-7.0%) |
| Dec 2007 | -$10.23M(+32.0%) | -$1.38M(-49.8%) | -$10.23M(+0.1%) |
| Sep 2007 | - | -$2.76M(-29.5%) | -$10.21M(+6.5%) |
| Jun 2007 | - | -$3.91M(+79.3%) | -$9.59M(+17.6%) |
| Mar 2007 | - | -$2.18M(+59.4%) | -$8.16M(+5.2%) |
| Dec 2006 | -$7.75M(+24.1%) | -$1.37M(-35.8%) | -$7.75M(-8.2%) |
| Sep 2006 | - | -$2.13M(-14.0%) | -$8.44M(+9.1%) |
| Jun 2006 | - | -$2.48M(+39.6%) | -$7.74M(+14.8%) |
| Mar 2006 | - | -$1.78M(-13.9%) | -$6.74M(+8.0%) |
| Dec 2005 | -$6.24M(+9.7%) | -$2.06M(+44.7%) | -$6.24M(+1.1%) |
| Sep 2005 | - | -$1.43M(-3.6%) | -$6.18M(-0.3%) |
| Jun 2005 | - | -$1.48M(+15.7%) | -$6.19M(+8.9%) |
| Mar 2005 | - | -$1.28M(-35.9%) | -$5.69M(-0.0%) |
| Dec 2004 | -$5.69M(+64.9%) | -$2.00M(+38.4%) | -$5.69M(+5.2%) |
| Sep 2004 | - | -$1.44M(+48.2%) | -$5.41M(+20.5%) |
| Jun 2004 | - | -$973.00K(-24.0%) | -$4.49M(+7.3%) |
| Mar 2004 | - | -$1.28M(-25.3%) | -$4.19M(+21.3%) |
| Dec 2003 | -$3.45M(+350.8%) | -$1.72M(+227.8%) | -$3.45M(+160.3%) |
| Sep 2003 | - | -$523.20K(-21.8%) | -$1.33M(-10.1%) |
| Jun 2003 | - | -$668.70K(+22.9%) | -$1.47M(+113.6%) |
| Mar 2003 | - | -$544.30K(-232.7%) | -$690.30K(-9.8%) |
| Dec 2002 | -$765.70K(-82.9%) | $410.10K(-161.0%) | -$765.70K(-61.0%) |
| Sep 2002 | - | -$671.80K(-680.6%) | -$1.96M(+4.7%) |
| Jun 2002 | - | $115.70K(-118.7%) | -$1.88M(-30.9%) |
| Mar 2002 | - | -$619.70K(-21.4%) | -$2.72M(-39.3%) |
| Dec 2001 | -$4.47M(+288.1%) | -$788.80K(+35.3%) | -$4.47M(+105.5%) |
| Sep 2001 | - | -$583.00K(-19.6%) | -$2.18M(-1.1%) |
| Jun 2001 | - | -$724.80K(-69.5%) | -$2.20M(-29.2%) |
| Mar 2001 | - | -$2.38M(-257.6%) | -$3.11M(+169.5%) |
| Dec 2000 | -$1.15M(-49.9%) | $1.51M(-348.9%) | -$1.15M(-59.7%) |
| Sep 2000 | - | -$606.20K(-62.9%) | -$2.86M(+7.8%) |
| Jun 2000 | - | -$1.63M(+285.2%) | -$2.66M(+38.0%) |
| Mar 2000 | - | -$423.60K(+111.8%) | -$1.92M(-16.4%) |
| Dec 1999 | -$2.30M(-11.5%) | -$200.00K(-50.0%) | -$2.30M(-30.3%) |
| Sep 1999 | - | -$400.00K(-55.6%) | -$3.30M(-21.4%) |
| Jun 1999 | - | -$900.00K(+12.5%) | -$4.20M(+110.0%) |
| Mar 1999 | - | -$800.00K(-33.3%) | -$2.00M(-23.1%) |
| Dec 1998 | -$2.60M(-36.6%) | -$1.20M(-7.7%) | -$2.60M(0.0%) |
| Sep 1998 | - | -$1.30M(-200.0%) | -$2.60M(+8.3%) |
| Jun 1998 | - | $1.30M(-192.9%) | -$2.40M(-48.9%) |
| Mar 1998 | - | -$1.40M(+16.7%) | -$4.70M(+14.6%) |
| Dec 1997 | -$4.10M(+2.5%) | -$1.20M(+9.1%) | -$4.10M(+41.4%) |
| Sep 1997 | - | -$1.10M(+10.0%) | -$2.90M(+61.1%) |
| Jun 1997 | - | -$1.00M(+25.0%) | -$1.80M(+125.0%) |
| Mar 1997 | - | -$800.00K | -$800.00K |
| Dec 1996 | -$4.00M | - | - |
FAQ
- What is TG Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for TG Therapeutics?
- What is TG Therapeutics annual CFO year-on-year change?
- What is TG Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for TG Therapeutics?
- What is TG Therapeutics quarterly CFO year-on-year change?
- What is TG Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for TG Therapeutics?
- What is TG Therapeutics TTM CFO year-on-year change?
What is TG Therapeutics annual cash flow from operations?
The current annual CFO of TGTX is -$40.52M
What is the all time high annual CFO for TG Therapeutics?
TG Therapeutics all-time high annual cash flow from operations is -$86.60K
What is TG Therapeutics annual CFO year-on-year change?
Over the past year, TGTX annual cash flow from operations has changed by -$9.10M (-28.98%)
What is TG Therapeutics quarterly cash flow from operations?
The current quarterly CFO of TGTX is -$28.71M
What is the all time high quarterly CFO for TG Therapeutics?
TG Therapeutics all-time high quarterly cash flow from operations is $83.70M
What is TG Therapeutics quarterly CFO year-on-year change?
Over the past year, TGTX quarterly cash flow from operations has changed by -$20.51M (-249.88%)
What is TG Therapeutics TTM cash flow from operations?
The current TTM CFO of TGTX is -$61.02M
What is the all time high TTM CFO for TG Therapeutics?
TG Therapeutics all-time high TTM cash flow from operations is $67.82M
What is TG Therapeutics TTM CFO year-on-year change?
Over the past year, TGTX TTM cash flow from operations has changed by -$81.31M (-400.88%)